{"meta":{"query_hash":"c281624b7d2e","filters":{"venue":"Journal of Central Nervous System Disease"},"cohort_total":14,"direct_labels_cover":0,"predictions_cover":14,"exported":14,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c281624b7d2e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Central+Nervous+System+Disease"},"results":[{"id":"W1981640307","doi":"10.4137/jcnsd.s5120","title":"Safety and Efficacy of Fingolimod in Treatment-Naïve Multiple Sclerosis Patients","year":2011,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Fingolimod; Multiple sclerosis; Medicine; Relapsing remitting; Adverse effect; Disease; Intensive care medicine; Physical therapy; Internal medicine; Immunology","score_opus":0.05738348288276247,"score_gpt":0.2646738614946622,"score_spread":0.20729037861189975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981640307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98456836,0.009308725,0.00021707619,0.0006791172,0.000051208266,0.00016156211,0.0005337719,0.00002689322,0.004453396],"genre_scores_gemma":[0.99642795,0.0015382047,0.00018985869,0.0005239148,0.0001738293,0.00009122656,0.0004637763,0.000004146242,0.0005870884],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984598,0.0008096247,0.00016354876,0.00013633457,0.0003604674,0.00007033427],"domain_scores_gemma":[0.99621576,0.0015798056,0.0012241947,0.00023592265,0.00036316545,0.0003811702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031556168,0.0001717285,0.00096284534,0.00037127853,0.0005056915,0.0005046437,0.00024783326,0.0007324943,0.0014125488],"category_scores_gemma":[0.006402174,0.00013795555,0.00054587517,0.0003971733,0.00029033519,0.00037550912,0.00017505935,0.00079925795,0.00036815892],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19477549,0.0086004445,0.40516838,0.0013226888,0.0018272228,0.0020597358,0.0012994048,0.0007602012,0.020536589,0.00053890195,0.003051929,0.3600589],"study_design_scores_gemma":[0.021133557,0.14827159,0.8104004,0.0002487907,0.0012830651,0.0029401588,0.0003078051,0.0009282035,0.004848753,0.0006388459,0.0089376345,0.00006120069],"about_ca_topic_score_codex":0.0003301609,"about_ca_topic_score_gemma":0.000430267,"teacher_disagreement_score":0.0031556168,"about_ca_system_score_codex":0.00030927872,"about_ca_system_score_gemma":0.00041488526,"threshold_uncertainty_score":0.016688704},"labels":[],"label_agreement":null},{"id":"W2017914285","doi":"10.4137/jcnsd.s13570","title":"Medical Treatment of Essential Tremor","year":2014,"lang":"en","type":"review","venue":"Journal of Central Nervous System Disease","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"Royal University Hospital Foundation","keywords":"Primidone; Essential tremor; Clonazepam; Medicine; Postural tremor; Propranolol; Physical medicine and rehabilitation; Resting tremor; Physical therapy; Anesthesia; Psychiatry; Parkinsonism; Carbamazepine; Internal medicine; Epilepsy; Disease","score_opus":0.02513982043360828,"score_gpt":0.3227824312657201,"score_spread":0.2976426108321118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017914285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054293516,0.996754,0.00011614954,0.0001528326,0.00013389552,0.000009248188,0.000029098954,0.00001247699,0.0022493834],"genre_scores_gemma":[0.005223564,0.9928814,0.0003042612,0.00030907092,0.00020845461,0.000015374519,0.00009906406,0.0000029442797,0.00095580483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998549,0.000025668842,0.000024321043,0.00002448787,0.000054026408,0.000016564898],"domain_scores_gemma":[0.99986804,0.00006334574,0.000026833683,0.0000050603103,0.000024941284,0.000011816107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024810518,0.00053003087,0.00097620336,0.0017745256,0.00026780358,0.00041635815,0.0005835156,0.00079853775,0.004013452],"category_scores_gemma":[0.0004892197,0.000120228615,0.0005713451,0.0007070279,0.00020972885,0.0003688798,0.00037658942,0.0009057239,0.0014276596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088273875,0.00012851688,0.0001936986,0.017181749,0.00014036585,0.00057660224,0.00005180794,0.00015836289,0.0017865815,0.000961453,0.022040503,0.956692],"study_design_scores_gemma":[0.00015661477,0.000323148,0.004551471,0.012874097,0.00038171522,0.01208668,0.000096932665,0.0001541045,0.0015392334,0.0018712113,0.9659364,0.000028409957],"about_ca_topic_score_codex":0.00073581573,"about_ca_topic_score_gemma":0.0016521339,"teacher_disagreement_score":0.004013452,"about_ca_system_score_codex":0.0002939294,"about_ca_system_score_gemma":0.00040328578,"threshold_uncertainty_score":0.013426304},"labels":[],"label_agreement":null},{"id":"W2113626944","doi":"10.4137/jcnsd.s1611","title":"Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications","year":2011,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; 3M (Canada); Amgen (Canada)","funders":"Universidad de Buenos Aires; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Insomnia; Melatonin; Medicine; Placebo; Pharmacology; Psychology; Anesthesia; Internal medicine","score_opus":0.033625781253356954,"score_gpt":0.2885577998119702,"score_spread":0.25493201855861325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113626944","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5774201,0.398107,0.0030076068,0.004029016,0.00026256792,0.00046870817,0.00017180838,0.0002004166,0.016332766],"genre_scores_gemma":[0.8808833,0.110108145,0.003955066,0.0011242898,0.00059491914,0.00023845985,0.00019869758,0.000024079982,0.0028731849],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997944,0.000086743596,0.00002720257,0.000019384706,0.000051183844,0.000021198479],"domain_scores_gemma":[0.99975985,0.00007805138,0.000079431346,0.000012224099,0.000034675973,0.00003586495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092695345,0.00041978495,0.00068302406,0.0005520002,0.00018718852,0.00031703027,0.00041934516,0.00055619836,0.0017125119],"category_scores_gemma":[0.00067588285,0.000104843675,0.0005095891,0.00031998116,0.00027944607,0.0003141102,0.00020586545,0.00079046347,0.0003088865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010133532,0.0031656567,0.0031728004,0.0023501115,0.00020196676,0.0007947788,0.0002019263,0.00034333626,0.074480526,0.00053323316,0.0015042664,0.9031179],"study_design_scores_gemma":[0.04156918,0.27686745,0.32302135,0.003386085,0.001666435,0.016513238,0.00090655446,0.00550927,0.14668523,0.0037018384,0.17991114,0.00026229367],"about_ca_topic_score_codex":0.00036907665,"about_ca_topic_score_gemma":0.0012295031,"teacher_disagreement_score":0.0017125119,"about_ca_system_score_codex":0.0003210972,"about_ca_system_score_gemma":0.0003242095,"threshold_uncertainty_score":0.0057289004},"labels":[],"label_agreement":null},{"id":"W3001091229","doi":"10.1177/1179573519899471","title":"The Impact of Rehabilitation-oriented Virtual Reality Device in Patients With Ischemic Stroke in the Early Subacute Recovery Phase: Study Protocol for a Phase III, Single-Blinded, Randomized, Controlled Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Rehabilitation; Randomized controlled trial; Medicine; Protocol (science); Physical therapy; Physical medicine and rehabilitation; Stroke (engine); Ischemic stroke; Clinical trial; Single blind; Surgery; Ischemia; Internal medicine; Alternative medicine; Pathology; Engineering","score_opus":0.0393145318843309,"score_gpt":0.3909628404873979,"score_spread":0.35164830860306695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001091229","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077173314,0.00038440275,0.0013397379,0.00024227312,0.00042618747,0.98851216,0.0005997441,0.000084481064,0.0006936791],"genre_scores_gemma":[0.0077898623,0.00023435405,0.0020172452,0.00031962426,0.0001270385,0.9889346,0.00015191689,0.000005533356,0.000419824],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9836559,0.010148561,0.0015116836,0.0013471735,0.0016764405,0.0016600902],"domain_scores_gemma":[0.9889761,0.00280617,0.0026246272,0.0013211357,0.0021529123,0.0021191326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025638543,0.006345686,0.010504153,0.0018883987,0.002723629,0.003493023,0.003596602,0.008489569,0.027948564],"category_scores_gemma":[0.022196334,0.002241638,0.004457469,0.0023963102,0.004044267,0.0028571398,0.001655885,0.0064326385,0.006099308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9597897,0.017852884,0.0003791417,0.005080263,0.0010179749,0.00010468234,0.00014088565,0.0009037458,0.0015494295,0.0008058763,0.002781525,0.009593906],"study_design_scores_gemma":[0.9581786,0.03588222,0.0006080219,0.00038309686,0.00032182384,0.00002078064,0.000031031494,0.0005084508,0.00031894047,0.00041821308,0.0032949073,0.000034062097],"about_ca_topic_score_codex":0.0012106788,"about_ca_topic_score_gemma":0.0023870221,"teacher_disagreement_score":0.027948564,"about_ca_system_score_codex":0.0031465236,"about_ca_system_score_gemma":0.013386468,"threshold_uncertainty_score":0.13559115},"labels":[],"label_agreement":null},{"id":"W3109019868","doi":"10.1177/1179573520973819","title":"Atypical Neuromyelitis Optica Spectrum Disorder With Diffuse Cerebral Abnormalities: A Case Report","year":2020,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neuromyelitis optica; Medicine; Spectrum disorder; Aquaporin 4; Spinal cord; White matter; Neuroimaging; Hyperintensity; Pathology; Myelopathy; Magnetic resonance imaging; Radiology; Multiple sclerosis; Immunology; Psychiatry","score_opus":0.021991281671635995,"score_gpt":0.25659342764011356,"score_spread":0.23460214596847756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109019868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97637117,0.0075805914,0.0024412556,0.0022176446,0.00041109772,0.00022579615,0.00027562602,0.00014941061,0.010327532],"genre_scores_gemma":[0.9928,0.0026506027,0.0013901294,0.0007472936,0.0010178954,0.000047870315,0.000144536,0.000019518648,0.0011820722],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991055,0.00009261811,0.000107205226,0.00022531489,0.00013061096,0.00033871867],"domain_scores_gemma":[0.9983633,0.00036337122,0.00044674816,0.0001516063,0.000107630025,0.000567347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005304847,0.0029096138,0.0013562862,0.0031375415,0.0038847167,0.0022885588,0.0015752825,0.0043979743,0.0019261168],"category_scores_gemma":[0.0027561057,0.0015127171,0.0012058005,0.0025075567,0.0023340997,0.002551813,0.0027367456,0.0032774298,0.0011119922],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014511639,0.000045058467,0.003935362,0.000028040238,0.000008661066,0.99445623,0.00017126201,0.000032252978,0.00029398967,0.00008241586,0.00016512035,0.0007671802],"study_design_scores_gemma":[0.0000086495575,0.000042921874,0.0034826156,0.000009660973,0.000009189231,0.99577713,0.00011479525,0.000092591,0.00008734561,0.000067284716,0.00029914748,0.00000867952],"about_ca_topic_score_codex":0.004067477,"about_ca_topic_score_gemma":0.006067153,"teacher_disagreement_score":0.0043979743,"about_ca_system_score_codex":0.0016224664,"about_ca_system_score_gemma":0.0013915474,"threshold_uncertainty_score":0.011771858},"labels":[],"label_agreement":null},{"id":"W3178503731","doi":"10.1177/11795735211029114","title":"Salivary Heme Oxygenase-1: A Potential Biomarker for Central Neurodegeneration","year":2021,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Parkinson Canada; Mitacs","keywords":"Biomarker; Neurodegeneration; Medicine; Saliva; Internal medicine; Population; Parkinson's disease; Gastroenterology; Degenerative disease; Pathology; Heme oxygenase; Disease; Heme; Biology; Biochemistry","score_opus":0.009466947513216278,"score_gpt":0.22789886731968415,"score_spread":0.21843191980646787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178503731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715465,0.021954425,0.002801058,0.00056169316,0.00007208402,0.0000977677,0.0014160129,0.00009632486,0.0014542644],"genre_scores_gemma":[0.9954325,0.001686074,0.0020514352,0.000102437,0.000062028885,0.000042262236,0.00036709633,0.0000037180325,0.00025252005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993907,0.00025212188,0.000051054092,0.00013115909,0.00012671815,0.000048161182],"domain_scores_gemma":[0.9978879,0.00043662929,0.0011424196,0.0000726546,0.0003382304,0.00012218893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017546712,0.00064854324,0.00064113864,0.0014762579,0.00026732983,0.0007715921,0.0004357313,0.00061012345,0.0010708093],"category_scores_gemma":[0.0025840302,0.00016266086,0.00036389715,0.0010889667,0.0003612772,0.00034550345,0.00044224886,0.0006457772,0.00024416344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087130046,0.00016371367,0.95191306,0.00047168182,0.0003587459,0.00016991478,0.00017352535,0.00030348645,0.011928839,0.000102856546,0.0008923009,0.032650623],"study_design_scores_gemma":[0.00002421889,0.00077861524,0.9890534,0.00014899361,0.00023957595,0.0012773705,0.00022024408,0.0018336853,0.0043616877,0.0004894532,0.0015520591,0.000020593114],"about_ca_topic_score_codex":0.0009103943,"about_ca_topic_score_gemma":0.00096323615,"teacher_disagreement_score":0.0017546712,"about_ca_system_score_codex":0.0003812463,"about_ca_system_score_gemma":0.00027853984,"threshold_uncertainty_score":0.009279728},"labels":[],"label_agreement":null},{"id":"W3191178877","doi":"10.1177/11795735211028781","title":"Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies","year":2021,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Placebo; Internal medicine; Post-hoc analysis; Age groups; Adverse effect; Pooled analysis; Demography; Confidence interval; Immunology; Pathology; Fingolimod","score_opus":0.056987497143042534,"score_gpt":0.32400585070450566,"score_spread":0.26701835356146314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191178877","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4670913,0.51678264,0.006490163,0.00047827652,0.0002961445,0.0013399661,0.005858824,0.00012519486,0.0015374144],"genre_scores_gemma":[0.95603,0.0355803,0.0025897098,0.00035149968,0.0003071272,0.00087969383,0.0041041425,0.000043741027,0.00011375525],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9420417,0.036360983,0.011480154,0.004829017,0.004541504,0.0007467119],"domain_scores_gemma":[0.90576077,0.045832332,0.03580787,0.006717504,0.004933565,0.00094790146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.092316195,0.0029017776,0.008784555,0.0063571003,0.00043689314,0.0035811565,0.0013889909,0.001639549,0.0012316979],"category_scores_gemma":[0.069748536,0.0014192394,0.025530271,0.0048980257,0.0009999465,0.0020902287,0.002360212,0.0010595577,0.00018945205],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033722762,0.0000878467,0.14987211,0.01582954,0.77559364,0.00017085699,0.00030433902,0.0016754225,0.001349862,0.00012031498,0.0005346909,0.020738674],"study_design_scores_gemma":[0.0065471553,0.005036373,0.26334623,0.0029950629,0.7158701,0.0007039845,0.00026165487,0.0009431553,0.0010104381,0.0004859237,0.0026746702,0.00012522424],"about_ca_topic_score_codex":0.000640955,"about_ca_topic_score_gemma":0.0009107708,"teacher_disagreement_score":0.092316195,"about_ca_system_score_codex":0.0007942974,"about_ca_system_score_gemma":0.0007954975,"threshold_uncertainty_score":0.4882205},"labels":[],"label_agreement":null},{"id":"W4393234802","doi":"10.1177/11795735241241423","title":"Meningoencephalitis in a novel mutation in MNGIE (mitochondrial neurogastrointestinal encephalomyopathy) ending a familial diagnostic odyssey: A case series report","year":2024,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Exome sequencing; Genetics; Thymidine phosphorylase; Meningoencephalitis; Population; Medicine; Biology; Phenotype; Pathology; Gene; Cancer","score_opus":0.00966804753211572,"score_gpt":0.25991903318878906,"score_spread":0.25025098565667336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393234802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338454,0.0026122492,0.0010505312,0.00032610854,0.00009454581,0.00010914876,0.00016955505,0.00006767048,0.0021857081],"genre_scores_gemma":[0.99711835,0.0010876972,0.00051224895,0.00020997379,0.00024270942,0.000017313374,0.00012480796,0.0000144148835,0.0006725395],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994468,0.000042337077,0.00008030549,0.0002036574,0.00007282315,0.00015404375],"domain_scores_gemma":[0.99904054,0.00017354717,0.00027926237,0.00009882,0.00006920144,0.00033853634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027222937,0.0016580715,0.0012017952,0.0020084362,0.0018964219,0.0014301729,0.00063177856,0.0020883786,0.0021211132],"category_scores_gemma":[0.001578008,0.0011166453,0.0011308355,0.0012110907,0.0012054621,0.0013829173,0.0013826045,0.001135105,0.0006924978],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062730534,0.000059206697,0.020699771,0.00005164484,0.000035493656,0.9756752,0.00027781885,0.000037040216,0.0010451191,0.00005263723,0.0002414616,0.0017618543],"study_design_scores_gemma":[0.000019689385,0.00008208113,0.017378535,0.000014838338,0.00006049,0.98117214,0.00014048032,0.00014077403,0.0004204466,0.000059010476,0.00049693463,0.000014600157],"about_ca_topic_score_codex":0.0019500556,"about_ca_topic_score_gemma":0.0018627535,"teacher_disagreement_score":0.0021211132,"about_ca_system_score_codex":0.00071640784,"about_ca_system_score_gemma":0.0004916415,"threshold_uncertainty_score":0.0070958734},"labels":[],"label_agreement":null},{"id":"W4396662992","doi":"10.1177/11795735241249693","title":"From progression to progress: The future of multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Novartis (Canada); Montreal Neurological Institute and Hospital; University of Calgary; St. Michael's Hospital","funders":"Novartis Pharmaceuticals Canada","keywords":"Disease; Medicine; Intensive care medicine; Mechanism (biology); Personalized medicine; Multiple sclerosis; Precision medicine; Biomarker; Biomarker discovery; Bioinformatics; Pathology; Psychiatry","score_opus":0.03025670588610446,"score_gpt":0.30708981411917313,"score_spread":0.27683310823306867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396662992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010208436,0.6257579,0.001205496,0.35667685,0.00837263,0.000009047296,0.00008477975,0.00012524819,0.00674722],"genre_scores_gemma":[0.055803806,0.81883025,0.004051675,0.08797185,0.026825545,0.00008139399,0.00014378208,0.00008911879,0.0062025366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99482286,0.002441416,0.00036626685,0.0005651806,0.0012763663,0.0005279502],"domain_scores_gemma":[0.9844087,0.00809562,0.000876417,0.00070778787,0.0027394365,0.0031721033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01181586,0.0008805593,0.0018840205,0.0025825803,0.0031224787,0.010494947,0.0018794967,0.008901269,0.009565767],"category_scores_gemma":[0.019061025,0.0003992422,0.0010018197,0.0016888847,0.013037568,0.01781817,0.0053080646,0.013965932,0.002446656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003317661,0.000107380496,0.0020802708,0.002774025,0.000108382046,0.0004465738,0.0038388663,0.00054808956,0.00053305255,0.10954505,0.2341995,0.64548695],"study_design_scores_gemma":[0.00005130508,0.00018421601,0.0023875036,0.0060507758,0.00008738822,0.0009572408,0.003720148,0.00053326716,0.00020891795,0.24716595,0.7385108,0.00014266573],"about_ca_topic_score_codex":0.008697133,"about_ca_topic_score_gemma":0.012275056,"teacher_disagreement_score":0.01181586,"about_ca_system_score_codex":0.0069955657,"about_ca_system_score_gemma":0.013287717,"threshold_uncertainty_score":0.062488973},"labels":[],"label_agreement":null},{"id":"W4401921750","doi":"10.1177/11795735241274186","title":"Diagnostic value of soluble Interleukin-2 receptor in patients suffering neurosarcoidosis: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of Central Nervous System Disease","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sächsische Landesbibliothek – Staats- und Universitätsbibliothek Dresden; Technische Universität Dresden; Deutsche Forschungsgemeinschaft","keywords":"Neurosarcoidosis; Medicine; Cochrane Library; Internal medicine; Sarcoidosis; MEDLINE; Randomized controlled trial; Systematic review","score_opus":0.024895782645933087,"score_gpt":0.32193805968863937,"score_spread":0.2970422770427063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401921750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032592406,0.9953419,0.0001042235,0.0002031355,0.00009559345,0.0003257008,0.00046885398,0.00000772439,0.00019365273],"genre_scores_gemma":[0.05631418,0.94022095,0.0007546663,0.00079301593,0.0001459063,0.0010996253,0.00052638893,0.0000074420827,0.00013779552],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930963,0.0018482826,0.0034235949,0.00058334996,0.000874537,0.00017393562],"domain_scores_gemma":[0.970923,0.019768681,0.0065116086,0.00033598914,0.0021315736,0.00032914284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053763357,0.001249748,0.008521547,0.0105487965,0.00056943437,0.0022063178,0.001825121,0.0020811972,0.0033384613],"category_scores_gemma":[0.02964612,0.00096374744,0.0061803535,0.009854312,0.0010185756,0.0019551506,0.0012296453,0.0006816871,0.00024028635],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034178383,0.000015122846,0.0021812464,0.96996033,0.010487161,0.00013834209,0.00015263181,0.00004902359,0.00014926809,0.00007129537,0.0006805875,0.015773246],"study_design_scores_gemma":[0.00066697766,0.0003868767,0.0116093345,0.8298686,0.1458358,0.0009888009,0.0004272141,0.000117561554,0.0002668348,0.00020428034,0.009565511,0.000062255305],"about_ca_topic_score_codex":0.0050899806,"about_ca_topic_score_gemma":0.012609575,"teacher_disagreement_score":0.0105487965,"about_ca_system_score_codex":0.002665713,"about_ca_system_score_gemma":0.0071267975,"threshold_uncertainty_score":0.028433144},"labels":[],"label_agreement":null},{"id":"W4403886581","doi":"10.1177/11795735241292185","title":"Measurement of cerebral venous oxygenation with quantitative susceptibility mapping after subarachnoid hemorrhage: A pilot study","year":2024,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China; National Science Foundation","keywords":"Subarachnoid hemorrhage; Oxygenation; Medicine; Anesthesia; Cardiology","score_opus":0.027799711764195368,"score_gpt":0.25768959373575157,"score_spread":0.2298898819715562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403886581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995926,0.00006626767,0.00017484467,0.0000064422156,0.0000036441274,0.00004377804,0.000020017202,0.0000027398378,0.00008965827],"genre_scores_gemma":[0.9992907,0.00008149479,0.0003788382,0.00001585489,0.000015647192,0.000074782256,0.000059418573,0.0000010345047,0.00008217055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996846,0.00014838428,0.00001594802,0.000045994406,0.00005502112,0.000049996637],"domain_scores_gemma":[0.9991321,0.0001974794,0.00022450175,0.000115569106,0.000120928635,0.00020943991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085142726,0.0005095486,0.00046224165,0.00032738637,0.00034518444,0.00023276094,0.00027750107,0.00032034103,0.00071817863],"category_scores_gemma":[0.0012580035,0.00016214627,0.00026782756,0.00020651738,0.0006422146,0.00032472363,0.00031290296,0.00045200594,0.00013564192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05860831,0.025920806,0.7031414,0.0003135117,0.00047312403,0.0034701922,0.0026955097,0.0004982351,0.13363583,0.00013978807,0.00033003735,0.07077332],"study_design_scores_gemma":[0.0020104742,0.20272608,0.7724328,0.000014617482,0.00023114083,0.0022478849,0.0008214732,0.00096205826,0.017672267,0.00014066191,0.0007029857,0.00003766288],"about_ca_topic_score_codex":0.0012293345,"about_ca_topic_score_gemma":0.0013579878,"teacher_disagreement_score":0.0012293345,"about_ca_system_score_codex":0.00021171513,"about_ca_system_score_gemma":0.00042260476,"threshold_uncertainty_score":0.004502833},"labels":[],"label_agreement":null},{"id":"W4407388582","doi":"10.1177/11795735251314881","title":"Prevalence and outcomes of mild stroke patients undergoing reperfusion therapy: A meta-analysis and SAFE recommendations for optimal management","year":2025,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Government of Canada; Fondazione Cariplo; Canadian Institutes of Health Research; Australian Academy of Science; National Cerebral and Cardiovascular Center","keywords":"Medicine; Thrombolysis; Stroke (engine); Intracerebral hemorrhage; Meta-analysis; Adverse effect; Odds ratio; Internal medicine; Reperfusion therapy; Cochrane Library; MEDLINE; Physical therapy; Subarachnoid hemorrhage; Ischemia; Myocardial infarction","score_opus":0.023457493685736647,"score_gpt":0.2889573724599556,"score_spread":0.265499878774219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407388582","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009949103,0.9841271,0.0027150263,0.0011238724,0.00025084443,0.000363684,0.0010146893,0.000057322923,0.0003983787],"genre_scores_gemma":[0.51441807,0.46717915,0.010952372,0.00228961,0.0006288701,0.0018169258,0.0022270996,0.000096929274,0.00039112935],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97605,0.015184587,0.0049261134,0.0018972021,0.0014744253,0.0004676553],"domain_scores_gemma":[0.9658183,0.025067661,0.0054430394,0.0015288816,0.0017353353,0.0004068465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035010662,0.003059198,0.01691064,0.007265147,0.0005774351,0.003989708,0.003017701,0.0028036293,0.0031258112],"category_scores_gemma":[0.05890326,0.0018007973,0.0642029,0.005307528,0.00073870237,0.0019606908,0.001716792,0.0020941314,0.00033291453],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002247387,0.000024410409,0.011063118,0.094615534,0.8785801,0.00010403409,0.00006304993,0.0012980534,0.00013254918,0.00022288112,0.00066951563,0.010979464],"study_design_scores_gemma":[0.00064397336,0.00012452762,0.0055437465,0.010832289,0.9805675,0.00006455701,0.000032427863,0.0006048906,0.000076821954,0.0004653137,0.0010170833,0.000026947197],"about_ca_topic_score_codex":0.0059954543,"about_ca_topic_score_gemma":0.0073259436,"teacher_disagreement_score":0.035010662,"about_ca_system_score_codex":0.0023981268,"about_ca_system_score_gemma":0.003009193,"threshold_uncertainty_score":0.18515629},"labels":[],"label_agreement":null},{"id":"W4408345465","doi":"10.1177/11795735251322456","title":"<i>Bartonella henselae</i> , <i>Babesia odocoilei</i> and <i>Babesia divergens</i> -like MO-1 infection in the brain of a child with seizures, mycotoxin exposure and suspected Rasmussen's encephalitis","year":2025,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Bartonella species infections research","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"State of North Carolina; Steven and Alexandra Cohen Foundation","keywords":"Bartonella; Biology; Encephalitis; Virology; Bartonella henselae; Babesia; Serology; Polymerase chain reaction; Immunology; Antibody","score_opus":0.0037667807770797846,"score_gpt":0.21097204315102333,"score_spread":0.20720526237394354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408345465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510777,0.000688258,0.00016421279,0.0007240953,0.000038094076,0.0000696621,0.0002931455,0.00001873893,0.0028961934],"genre_scores_gemma":[0.99849486,0.0005525039,0.0002115126,0.00024294852,0.000050346993,0.000009568847,0.00012895948,0.0000047950325,0.00030460078],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99966466,0.000027956808,0.000046043606,0.00006517167,0.00006300531,0.000133178],"domain_scores_gemma":[0.9994036,0.00008603228,0.00016412855,0.000017245915,0.00007685284,0.00025215352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019602352,0.0009061093,0.00041952153,0.0015466904,0.0014922417,0.0006565083,0.00074956607,0.0013229456,0.0013752294],"category_scores_gemma":[0.0010470588,0.0006789364,0.00044659222,0.00083685113,0.0013166387,0.0008065046,0.00061371725,0.0017861811,0.00030688258],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016016152,0.00009909939,0.2899617,0.00009620636,0.000025304716,0.701292,0.0016026129,0.0001416589,0.0032228457,0.00014932611,0.0010695509,0.0021794275],"study_design_scores_gemma":[0.000017315817,0.0003129755,0.46465373,0.0001243401,0.00005487642,0.5286583,0.003147909,0.0004876513,0.0012568882,0.00015554258,0.0011018672,0.000028580394],"about_ca_topic_score_codex":0.057498697,"about_ca_topic_score_gemma":0.10296442,"teacher_disagreement_score":0.057498697,"about_ca_system_score_codex":0.0023862396,"about_ca_system_score_gemma":0.0014302104,"threshold_uncertainty_score":0.11432803},"labels":[],"label_agreement":null},{"id":"W4415174656","doi":"10.1177/11795735251388781","title":"Fecal Microbiota Transplantation for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":2025,"lang":"en","type":"review","venue":"Journal of Central Nervous System Disease","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Randomized controlled trial; Fecal bacteriotherapy; Feces; Transplantation; Clinical endpoint; Dysbiosis","score_opus":0.041363920535136635,"score_gpt":0.3543064985028668,"score_spread":0.3129425779677301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415174656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014819361,0.9970878,0.0003111179,0.00014620724,0.000101240024,0.00037179803,0.00033112895,0.000016833668,0.00015191131],"genre_scores_gemma":[0.05785934,0.936486,0.0020393482,0.0008692825,0.00023480199,0.0016952701,0.00058566884,0.000023134333,0.00020723892],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98857903,0.005306612,0.0034961882,0.0010887563,0.0011783201,0.00035107156],"domain_scores_gemma":[0.97886306,0.015338833,0.0036454923,0.00042619553,0.0014573224,0.00026910246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0144677535,0.0029173587,0.023528222,0.0070071984,0.0007685664,0.0032355557,0.0024249833,0.002471532,0.006007885],"category_scores_gemma":[0.036027513,0.0011987888,0.031676535,0.0074500013,0.00083876314,0.0021306896,0.0014948032,0.002183586,0.00035903818],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025218339,0.000040742252,0.0012721317,0.713487,0.2612677,0.00007759051,0.000058707858,0.00036376587,0.00015676269,0.00014468799,0.00070675067,0.019902388],"study_design_scores_gemma":[0.001872865,0.0003726268,0.0027403918,0.09680582,0.8944618,0.00010402172,0.00005704825,0.00022202075,0.0001210255,0.00032562204,0.0028854667,0.000031428845],"about_ca_topic_score_codex":0.006686052,"about_ca_topic_score_gemma":0.013552323,"teacher_disagreement_score":0.023528222,"about_ca_system_score_codex":0.0032904968,"about_ca_system_score_gemma":0.0048111267,"threshold_uncertainty_score":0.07651377},"labels":[],"label_agreement":null}]}